A critical situation has emerged involving the storage of stem cell samples from the defunct Biobank, which were temporarily taken over by the company GaiaCell following its collapse in 2024. The issue centers around a shortage of liquid nitrogen, essential for maintaining the ultra-low temperatures required to preserve these biological materials. According to reports, GaiaCell informed the Public Agency for Medicines and Medical Devices (JAZMP) on Wednesday that the reservoir supplying liquid nitrogen to the cryocontainers had run dry. This shortage poses a growing risk as the temperature inside one of the containers has begun to rise, approaching the critical threshold of -140 degrees Celsius. While current conditions remain within acceptable limits, the potential threat to the integrity of the stored samples is becoming increasingly apparent.
The problem originated when the last refill of liquid nitrogen was carried out by supplier Istrabenz Plini on June 12. Since then, concerns have been raised about the gradual increase in temperature within the cryocontainers. These containers hold samples from individuals whose legal representatives or owners have either not signed agreements with new storage providers or have yet to transfer their samples. Some of these individuals chose to donate their samples for research or requested their destruction, but others remain undecided or uncontacted. The transition of these samples to new storage providers began in April, May, and June, indicating a recent shift in management and responsibility.
In response to this crisis, the District Court in Domžale issued a temporary order requiring GaiaCell to ensure the supply of liquid nitrogen until September 5. However, this directive applies exclusively to the samples of parents who initiated legal proceedings. Meanwhile, GaiaCell has emphasized that merely securing the supply of gas is insufficient for the operation of the cryobank. They argue that financial resources are also necessary to maintain the facility and continue the preservation process. In particular, they have criticized Izvorna Celica, another provider, for its lack of responsiveness. Despite having signed contracts for the continued storage of these samples, Izvorna Celica has not yet taken possession of them. GaiaCell claims that if Izvorna Celica had been genuinely committed to its clients, it would have promptly retrieved and relocated the vital samples.
GaiaCell took over approximately 4,000 children's stem cell samples after the Biobank’s collapse in 2024, despite lacking a contract for substitute storage. As of Saturday, the company stated that more than 1,200 of these vital samples had successfully been transferred to other facilities. This partial success highlights both the progress made and the ongoing challenges faced in ensuring the safe and timely relocation of all remaining samples. The urgency of the situation underscores the need for swift action and cooperation among all stakeholders, including the families, the legal system, and the service providers involved.
The situation has sparked discussions about the broader implications of such crises in the field of medical sample storage. It raises questions about the preparedness of companies handling sensitive biological material and the adequacy of contingency plans in place should unexpected circumstances arise. Additionally, it highlights the importance of clear communication and prompt decision-making between all parties involved—parents, legal representatives, and service providers—to prevent similar incidents in the future. The involvement of multiple entities, each playing a crucial role in the chain of custody and care for these valuable samples, emphasizes the complexity of managing such responsibilities effectively.
As the deadline set by the court approaches, the pressure on GaiaCell intensifies. The company must navigate not only the immediate challenge of securing enough liquid nitrogen to maintain the required temperatures but also the logistical hurdles of transferring the remaining samples to alternative storage solutions. The cooperation of Izvorna Celica remains a pivotal factor in determining how quickly and efficiently this can be accomplished. With time running out, the focus shifts toward resolving outstanding contractual obligations and ensuring that the most vulnerable samples receive the attention they require before irreversible damage occurs. The coming weeks will likely determine whether the situation is managed successfully or leads to further complications in the already delicate landscape of stem cell banking.
3 reports
N1 SlovenijaIndependentCenterFactual 85Objective 708 days agoThe article reports on a critical situation at GaiaCell in Trzin, where some storage tanks for stem cell samples are experiencing rising temperatures due to a shortage of liquid nitrogen. The Slovenian Public Agency for Health and Medical Advice has warned that the temperature is approaching the critical threshold of -140°C. Some sample owners have signed agreements with new storage providers, but these have not yet been fulfilled. GaiaCell was informed of the nitrogen shortage on Wednesday, and the last refill was done by supplier Istrabenz on June 12. While a court order requires GaiaCell to provide nitrogen until September 5, this applies only to samples involved in legal proceedings. The article also notes that financial support is needed for the operation of the cryobank, and GaiaCell criticizes Izvorna Celica for not taking over the samples despite signed agreements. GaiaCell has temporarily taken over around 4,000 children’s samples since the bankruptcy of Biobanka in 2024, successfully transferring over 1,200 vital samples.
Bias read (Center): The article presents a factual report on a technical and administrative crisis involving multiple stakeholders, including private companies and regulatory bodies. There is no overt ideological framing or emphasis on specific political agendas. The tone remains neutral, focusing on the operational,法律
Why these scores (Factual 85 · Objective 70): Very detailed and aligned with other sources on the technical and legal aspects. However, there is a slight editorial tone when mentioning the lack of responsiveness from Izvorna celica, reducing objectivity.
24ur (POP TV)IndependentCenterFactual 80Objective 758 days agoThe article discusses a critical situation at the Biobank in Trzin, Slovenia, where the temperature in one of the containers holding stem cell samples has been rising due to a shortage of liquid nitrogen. The company GaiaCell, which temporarily took over the storage after the Biobank's bankruptcy in 2024, informed the agency last Wednesday about this issue. The last refill of liquid nitrogen was done by supplier Istrabenz Plini on June 12, and the agency warned about the risk of increasing temperatures by the end of last week. Samples stored in Trzin belong to individuals whose owners or legal representatives either haven’t signed agreements with new storage providers or have not donated the samples for research or requested their destruction. Transfers of these samples to new storage providers occurred in April, May, and June. Meanwhile, GaiaCell highlights that ensuring the operation of the cryobank requires more than just gas supply—it also needs financial support. They criticize Izvorna Celica for not taking over the samples under new contracts, stating they would have acted promptly if they were honest with their clients.
Bias read (Center): The article presents a factual account of a technical and logistical issue involving the storage of biological samples. It includes perspectives from multiple parties—GaiaCell, Izvorna Celica, and the agency—without overtly favoring any side. There is no clear ideological framing or biased language,
Why these scores (Factual 80 · Objective 75): Accurate reporting on the temperature rise and legal issues involving the companies. Slightly more emphasis on the legal aspects, which may introduce some bias, but remains largely objective.
DnevnikIndependent🔒CenterFactual 75Objective 808 days agoThe article reports that GaiaCell, which temporarily took over stem cell samples from the collapsed Biobank, has informed the Agency for Medicines and Medical Devices that the liquid nitrogen supply in their storage tanks is running low. This could lead to rising temperatures inside the cryocontainers, potentially reaching critical levels. The agency warns that some sample owners have not yet signed agreements with new storage providers like 'Izvorna Celica,' delaying the transfer of samples. Meanwhile, GaiaCell highlights financial challenges in maintaining operations and criticizes 'Izvorna Celica' for not taking over the samples as agreed. A temporary court order requires GaiaCell to ensure liquid nitrogen supply until September 5th, but this applies only to samples from parents who initiated legal action.
Bias read (Center): The article presents a factual account of the situation involving GaiaCell, the Biobank, and the Agency for Medicines and Medical Devices. It includes quotes from both GaiaCell and the agency, providing balanced perspectives without overtly favoring any side. There is no clear ideological framing or
Why these scores (Factual 75 · Objective 80): Factual accuracy is good, reporting on the shortage of liquid nitrogen and rising temperatures in storage tanks. The article provides details from GaiaCell and the agency, aligning with cross-source consensus. Objectivity is high, presenting facts without emotional language.
★
Keep the news honest.
ObjectiveNews is reader-funded and ad-free — we show you the bias instead of hiding it. Support independent journalism for €5/month.
Become a Supporter
Slovenia
